ARTICLE | Company News
Oxagen, Incyte osteoporosis deal
January 29, 2001 8:00 AM UTC
Genomics company Oxagen (Abingdon, U.K.) and Incyte (INCY) will investigate the genetics of osteoporosis. The parties will test for genetic association between key candidate genes and bone mineral den...